Lifordi Immunotherapeutics
Lifordi
- Employees
- 1–10
- Business Model
- B2B
- Website
- lifordi.com
- Last Round
- Venture RoundNov 2025
- Rounds
- 2
About
Biotech company developing antibody-drug conjugate (ADC) therapies for autoimmune and inflammatory disorders.
Summary
Lifordi Immunotherapeutics is a Biotech company. Its most recent funding was a Venture Round round in Nov 2025. Investors include ARCH Venture Partners, Sanofi Ventures and 5AM Ventures.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...